Our study therefore demonstrates that blood NfL level has a limited role in distinguishing ALS from non-ALS cases independent of clinical judgement, albeit in the specialized clinic setting where EMG and relevant negative neuroimaging will be readily available. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.